Year: 2024
Type: article
Study design: Observational Study
Abstract: Immune checkpoint inhibitors (CPI) induced diarrhoea and colitis (ir-colitis) are common immune-related adverse events. Ir-colitis management guidelines are based on expert consensus. This retrospective study presents real-world data on melanoma patients with ir-colitis requiring medical intervention. The objective was to describe treatment patterns, hypothesising that glucocorticoid (GC) use exceeds guidelines and that biologic treatment (BIOx) initiation is often delayed.
Source: Immuno-Oncology Technology
Institutions: University of Southern Denmark, Odense University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,170
Funder: Novo Nordisk Fonden
OpenAlex ID: W4405375268
